16
Views
1
CrossRef citations to date
0
Altmetric
Research Article

SQUAMOUS CELL CARCINOMA OF THE TONGUE AS A SECOND MALIGNANCY IN A PATIENT PREVIOUSLY TREATED FOR OSTEOSARCOMA

, , , , &
Pages 421-424 | Published online: 09 Jul 2009

REFERENCES

  • Mike V, Meadows AT, D'Angio GJ. Incidence of second malignant neoplasms in children. LanceL 1982;11:1326–1331.
  • Ochs J, Mulhern RK. Late effects of antileukemic treatment. Pediatr Clin North Am. 1988;35:815–833.
  • Sasaki K. Neoadjuvant chemotherapy for osteosarcoma in children. In: Kimura K, eds. Challenges for the Future Tokyo: Excerpta Medica; 1989:195–199.
  • Rosen G, Caparros B, Huvos AG, et al. Preoperative chemotherapy for osteogenic sarcoma. Cancer. 1982;49:1221–1230.
  • Pratt CB, Meyer WH, Luo X, et al. Second malignant neoplasms occurring in survivors of osteosar-coma. Cancer. 1997;80:960–965.
  • Meadows AT, D'Angio GJ, Mike V, et al. Patterns of second malignant neoplasms in children. Cancer. 1997;40:1903–1911.
  • Miniero R, Barisone E, Vivenza C, et al. Acute lymphoblastic leukemia in a girl treated for osteosar-coma. Pediatr Hematol Oncol. 1995;12:185–188.
  • Pappo A, Schneider NR, Sanders JM, et al. Secondary myelodysplastic syndrome complicating therapy for osteogenic sarcoma. Cancer. 1991;68:1373–1375.
  • van der Waal RIF, Snow GB, van der WAAL I. Oral squamous cell carcinoma as a second primary malignancy in a patient with previously diagnosed osteosarcoma of the femur. J Oral Maxillofac Slog. 1997;55:1156–1158.
  • Hawkins MM, Draper GJ, Kingston JE. Incidence of second primary tumors among childhood cancer survivors. Br J Cancer. 1987;56:339–347.
  • Robison LL, Mertens A. Second tumors after treatment of childhood malignancies. Hematol Oncol Clin North Am. 1993;7:401–415.
  • Newman AN, Rice DH, Ossoff RH, et al. Carcinoma of the tongue in persons younger than 30 years of age. Arch Otolaryngol. 1983;109:302–304.
  • McIntyre JF, Smith-Sorensen B, Friend SH, et al. Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. J Clin Oncol. 1994;12:925–930.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.